You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-CTLA4 antibody [BNI3] - Azide free (ab19792)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-CTLA4 antibody [BNI3] - Azide free
See all CTLA4 products (20) ...

Description

Mouse monoclonal [BNI3] to CTLA4 - Azide free

Tested applications

ICC, Flow Cyt, IHC-Frmore details

Cross reactivity

Reacts with

Human

Immunogen

Human CTLA-4/human IgG heavy chain fusion protein (CTLA-4/Ig).

Positive control

ICC/FACS: B cells

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: PBS, 1mg/ml BSA. pH 7.2

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Monoclonal

Clone number

BNI3

Myeloma

P3x63-Ag8.653

Isotype

IgG2a

Applications

Show applications key

Our Abpromise guarantee covers the use of ab19792 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.

Tissue specificity

Widely expressed with highest levels in lymphoid tissues. Detected in activated T-cells where expression levels are 30- to 50-fold less than CD28, the stimulatory coreceptor, on the cell surface following activation.

Involvement in disease

Genetic variation in CTLA4 influences susceptibility to systemic lupus erythematosus (SLE) [MIM:152700]. SLE is a chronic, inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin, joints, kidneys and serosal membranes. SLE is thought to represent a failure of the regulatory mechanisms of the autoimmune system.
Note=Genetic variations in CTLA4 may influence susceptibility to Graves disease, an autoimmune disorder associated with overactivity of the thyroid gland and hyperthyroidism.
Genetic variation in CTLA4 is the cause of susceptibility to diabetes mellitus insulin-dependent type 12 (IDDM12) [MIM:601388]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Genetic variation in CTLA4 is the cause of susceptibility to celiac disease type 3 (CELIAC3) [MIM:609755]. It is a multifactorial disorder of the small intestine that is influenced by both environmental and genetic factors. It is characterized by malabsorption resulting from inflammatory injury to the mucosa of the small intestine after the ingestion of wheat gluten or related rye and barley proteins. In its classic form, celiac disease is characterized in children by malabsorption and failure to thrive.

Sequence similarities

Contains 1 Ig-like V-type (immunoglobulin-like) domain.

Post-translational
modifications

N-glycosylation is important for dimerization.
Phosphorylation at Tyr-201 prevents binding to the AP-2 adapter complex, blocks endocytosis, and leads to retention of CTLA4 on the cell surface.

Cellular localization

Cell membrane. Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalisation and.

Target information above from: UniProt accessionP16410 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • CD 152 antibody
  • CD antibody
  • CD152 antibody
  • CD152 antigen antibody
  • Celiac disease 3 antibody
  • CELIAC3 antibody
  • CTLA 4 antibody
  • CTLA-4 antibody
  • CTLA4 antibody
  • CTLA4_HUMAN antibody
  • Cytotoxic T cell associated 4 antibody
  • Cytotoxic T lymphocyte associated 4 antibody
  • Cytotoxic T lymphocyte associated antigen 4 antibody
  • Cytotoxic T lymphocyte associated protein 4 antibody
  • Cytotoxic T lymphocyte associated serine esterase 4 antibody
  • Cytotoxic T lymphocyte protein 4 antibody
  • Cytotoxic T-lymphocyte protein 4 antibody
  • Cytotoxic T-lymphocyte-associated antigen 4 antibody
  • GRD4 antibody
  • GSE antibody
  • IDDM12 antibody
  • Ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4 antibody
  • OTTHUMP00000216623 antibody
see all

References for Anti-CTLA4 antibody [BNI3] - Azide free (ab19792)

This product has been referenced in:

See 1 publication for this product

Publishing research using ab19792? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"